Global Cyclic Peptide Compounds Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Cyclic Peptide Compounds market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Cyclic Peptide Compounds Industry Forecast” looks at past sales and reviews total world Cyclic Peptide Compounds sales in 2023, providing a comprehensive analysis by region and market sector of projected Cyclic Peptide Compounds sales for 2024 through 2030. With Cyclic Peptide Compounds sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyclic Peptide Compounds industry.
This Insight Report provides a comprehensive analysis of the global Cyclic Peptide Compounds landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyclic Peptide Compounds portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyclic Peptide Compounds market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyclic Peptide Compounds and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyclic Peptide Compounds.
United States market for Cyclic Peptide Compounds is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Cyclic Peptide Compounds is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Cyclic Peptide Compounds is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Cyclic Peptide Compounds players cover Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Bachem, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyclic Peptide Compounds market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Cyclic Peptide Compounds market?
What factors are driving Cyclic Peptide Compounds market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyclic Peptide Compounds market opportunities vary by end market size?
How does Cyclic Peptide Compounds break out by Type, by Application?
The global Cyclic Peptide Compounds market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Cyclic Peptide Compounds Industry Forecast” looks at past sales and reviews total world Cyclic Peptide Compounds sales in 2023, providing a comprehensive analysis by region and market sector of projected Cyclic Peptide Compounds sales for 2024 through 2030. With Cyclic Peptide Compounds sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyclic Peptide Compounds industry.
This Insight Report provides a comprehensive analysis of the global Cyclic Peptide Compounds landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyclic Peptide Compounds portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyclic Peptide Compounds market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyclic Peptide Compounds and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyclic Peptide Compounds.
United States market for Cyclic Peptide Compounds is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Cyclic Peptide Compounds is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Cyclic Peptide Compounds is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Cyclic Peptide Compounds players cover Bicycle Therapeutics, Apellis Pharmaceuticals, Merck, Bachem, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyclic Peptide Compounds market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Natural Cyclic Peptide
- Synthetic Cyclic Peptide
- Biopharmaceutical
- Environmental Protection
- Scientific Research
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bicycle Therapeutics
- Apellis Pharmaceuticals
- Merck
- Bachem
- Novartis
- Roche (Chugai Pharmabody Research)
- Biopharma PEG Scientific
- Pfizer
- AstraZeneca
- Eli Lilly
- GenScript Biotech
What is the 10-year outlook for the global Cyclic Peptide Compounds market?
What factors are driving Cyclic Peptide Compounds market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cyclic Peptide Compounds market opportunities vary by end market size?
How does Cyclic Peptide Compounds break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cyclic Peptide Compounds Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Cyclic Peptide Compounds by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Cyclic Peptide Compounds by Country/Region, 2019, 2023 & 2030
2.2 Cyclic Peptide Compounds Segment by Type
2.2.1 Natural Cyclic Peptide
2.2.2 Synthetic Cyclic Peptide
2.3 Cyclic Peptide Compounds Sales by Type
2.3.1 Global Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
2.3.2 Global Cyclic Peptide Compounds Revenue and Market Share by Type (2019-2024)
2.3.3 Global Cyclic Peptide Compounds Sale Price by Type (2019-2024)
2.4 Cyclic Peptide Compounds Segment by Application
2.4.1 Biopharmaceutical
2.4.2 Environmental Protection
2.4.3 Scientific Research
2.4.4 Others
2.5 Cyclic Peptide Compounds Sales by Application
2.5.1 Global Cyclic Peptide Compounds Sale Market Share by Application (2019-2024)
2.5.2 Global Cyclic Peptide Compounds Revenue and Market Share by Application (2019-2024)
2.5.3 Global Cyclic Peptide Compounds Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Cyclic Peptide Compounds Breakdown Data by Company
3.1.1 Global Cyclic Peptide Compounds Annual Sales by Company (2019-2024)
3.1.2 Global Cyclic Peptide Compounds Sales Market Share by Company (2019-2024)
3.2 Global Cyclic Peptide Compounds Annual Revenue by Company (2019-2024)
3.2.1 Global Cyclic Peptide Compounds Revenue by Company (2019-2024)
3.2.2 Global Cyclic Peptide Compounds Revenue Market Share by Company (2019-2024)
3.3 Global Cyclic Peptide Compounds Sale Price by Company
3.4 Key Manufacturers Cyclic Peptide Compounds Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyclic Peptide Compounds Product Location Distribution
3.4.2 Players Cyclic Peptide Compounds Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CYCLIC PEPTIDE COMPOUNDS BY GEOGRAPHIC REGION
4.1 World Historic Cyclic Peptide Compounds Market Size by Geographic Region (2019-2024)
4.1.1 Global Cyclic Peptide Compounds Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Cyclic Peptide Compounds Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Cyclic Peptide Compounds Market Size by Country/Region (2019-2024)
4.2.1 Global Cyclic Peptide Compounds Annual Sales by Country/Region (2019-2024)
4.2.2 Global Cyclic Peptide Compounds Annual Revenue by Country/Region (2019-2024)
4.3 Americas Cyclic Peptide Compounds Sales Growth
4.4 APAC Cyclic Peptide Compounds Sales Growth
4.5 Europe Cyclic Peptide Compounds Sales Growth
4.6 Middle East & Africa Cyclic Peptide Compounds Sales Growth
5 AMERICAS
5.1 Americas Cyclic Peptide Compounds Sales by Country
5.1.1 Americas Cyclic Peptide Compounds Sales by Country (2019-2024)
5.1.2 Americas Cyclic Peptide Compounds Revenue by Country (2019-2024)
5.2 Americas Cyclic Peptide Compounds Sales by Type (2019-2024)
5.3 Americas Cyclic Peptide Compounds Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyclic Peptide Compounds Sales by Region
6.1.1 APAC Cyclic Peptide Compounds Sales by Region (2019-2024)
6.1.2 APAC Cyclic Peptide Compounds Revenue by Region (2019-2024)
6.2 APAC Cyclic Peptide Compounds Sales by Type (2019-2024)
6.3 APAC Cyclic Peptide Compounds Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cyclic Peptide Compounds by Country
7.1.1 Europe Cyclic Peptide Compounds Sales by Country (2019-2024)
7.1.2 Europe Cyclic Peptide Compounds Revenue by Country (2019-2024)
7.2 Europe Cyclic Peptide Compounds Sales by Type (2019-2024)
7.3 Europe Cyclic Peptide Compounds Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cyclic Peptide Compounds by Country
8.1.1 Middle East & Africa Cyclic Peptide Compounds Sales by Country (2019-2024)
8.1.2 Middle East & Africa Cyclic Peptide Compounds Revenue by Country (2019-2024)
8.2 Middle East & Africa Cyclic Peptide Compounds Sales by Type (2019-2024)
8.3 Middle East & Africa Cyclic Peptide Compounds Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyclic Peptide Compounds
10.3 Manufacturing Process Analysis of Cyclic Peptide Compounds
10.4 Industry Chain Structure of Cyclic Peptide Compounds
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyclic Peptide Compounds Distributors
11.3 Cyclic Peptide Compounds Customer
12 WORLD FORECAST REVIEW FOR CYCLIC PEPTIDE COMPOUNDS BY GEOGRAPHIC REGION
12.1 Global Cyclic Peptide Compounds Market Size Forecast by Region
12.1.1 Global Cyclic Peptide Compounds Forecast by Region (2025-2030)
12.1.2 Global Cyclic Peptide Compounds Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Cyclic Peptide Compounds Forecast by Type (2025-2030)
12.7 Global Cyclic Peptide Compounds Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Bicycle Therapeutics
13.1.1 Bicycle Therapeutics Company Information
13.1.2 Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolios and Specifications
13.1.3 Bicycle Therapeutics Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bicycle Therapeutics Main Business Overview
13.1.5 Bicycle Therapeutics Latest Developments
13.2 Apellis Pharmaceuticals
13.2.1 Apellis Pharmaceuticals Company Information
13.2.2 Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolios and Specifications
13.2.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Apellis Pharmaceuticals Main Business Overview
13.2.5 Apellis Pharmaceuticals Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Cyclic Peptide Compounds Product Portfolios and Specifications
13.3.3 Merck Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Bachem
13.4.1 Bachem Company Information
13.4.2 Bachem Cyclic Peptide Compounds Product Portfolios and Specifications
13.4.3 Bachem Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bachem Main Business Overview
13.4.5 Bachem Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Cyclic Peptide Compounds Product Portfolios and Specifications
13.5.3 Novartis Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Roche (Chugai Pharmabody Research)
13.6.1 Roche (Chugai Pharmabody Research) Company Information
13.6.2 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolios and Specifications
13.6.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Roche (Chugai Pharmabody Research) Main Business Overview
13.6.5 Roche (Chugai Pharmabody Research) Latest Developments
13.7 Biopharma PEG Scientific
13.7.1 Biopharma PEG Scientific Company Information
13.7.2 Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolios and Specifications
13.7.3 Biopharma PEG Scientific Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biopharma PEG Scientific Main Business Overview
13.7.5 Biopharma PEG Scientific Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Cyclic Peptide Compounds Product Portfolios and Specifications
13.8.3 Pfizer Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 AstraZeneca
13.9.1 AstraZeneca Company Information
13.9.2 AstraZeneca Cyclic Peptide Compounds Product Portfolios and Specifications
13.9.3 AstraZeneca Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 AstraZeneca Main Business Overview
13.9.5 AstraZeneca Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Cyclic Peptide Compounds Product Portfolios and Specifications
13.10.3 Eli Lilly Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 GenScript Biotech
13.11.1 GenScript Biotech Company Information
13.11.2 GenScript Biotech Cyclic Peptide Compounds Product Portfolios and Specifications
13.11.3 GenScript Biotech Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 GenScript Biotech Main Business Overview
13.11.5 GenScript Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cyclic Peptide Compounds Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Cyclic Peptide Compounds by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Cyclic Peptide Compounds by Country/Region, 2019, 2023 & 2030
2.2 Cyclic Peptide Compounds Segment by Type
2.2.1 Natural Cyclic Peptide
2.2.2 Synthetic Cyclic Peptide
2.3 Cyclic Peptide Compounds Sales by Type
2.3.1 Global Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
2.3.2 Global Cyclic Peptide Compounds Revenue and Market Share by Type (2019-2024)
2.3.3 Global Cyclic Peptide Compounds Sale Price by Type (2019-2024)
2.4 Cyclic Peptide Compounds Segment by Application
2.4.1 Biopharmaceutical
2.4.2 Environmental Protection
2.4.3 Scientific Research
2.4.4 Others
2.5 Cyclic Peptide Compounds Sales by Application
2.5.1 Global Cyclic Peptide Compounds Sale Market Share by Application (2019-2024)
2.5.2 Global Cyclic Peptide Compounds Revenue and Market Share by Application (2019-2024)
2.5.3 Global Cyclic Peptide Compounds Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Cyclic Peptide Compounds Breakdown Data by Company
3.1.1 Global Cyclic Peptide Compounds Annual Sales by Company (2019-2024)
3.1.2 Global Cyclic Peptide Compounds Sales Market Share by Company (2019-2024)
3.2 Global Cyclic Peptide Compounds Annual Revenue by Company (2019-2024)
3.2.1 Global Cyclic Peptide Compounds Revenue by Company (2019-2024)
3.2.2 Global Cyclic Peptide Compounds Revenue Market Share by Company (2019-2024)
3.3 Global Cyclic Peptide Compounds Sale Price by Company
3.4 Key Manufacturers Cyclic Peptide Compounds Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyclic Peptide Compounds Product Location Distribution
3.4.2 Players Cyclic Peptide Compounds Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CYCLIC PEPTIDE COMPOUNDS BY GEOGRAPHIC REGION
4.1 World Historic Cyclic Peptide Compounds Market Size by Geographic Region (2019-2024)
4.1.1 Global Cyclic Peptide Compounds Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Cyclic Peptide Compounds Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Cyclic Peptide Compounds Market Size by Country/Region (2019-2024)
4.2.1 Global Cyclic Peptide Compounds Annual Sales by Country/Region (2019-2024)
4.2.2 Global Cyclic Peptide Compounds Annual Revenue by Country/Region (2019-2024)
4.3 Americas Cyclic Peptide Compounds Sales Growth
4.4 APAC Cyclic Peptide Compounds Sales Growth
4.5 Europe Cyclic Peptide Compounds Sales Growth
4.6 Middle East & Africa Cyclic Peptide Compounds Sales Growth
5 AMERICAS
5.1 Americas Cyclic Peptide Compounds Sales by Country
5.1.1 Americas Cyclic Peptide Compounds Sales by Country (2019-2024)
5.1.2 Americas Cyclic Peptide Compounds Revenue by Country (2019-2024)
5.2 Americas Cyclic Peptide Compounds Sales by Type (2019-2024)
5.3 Americas Cyclic Peptide Compounds Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyclic Peptide Compounds Sales by Region
6.1.1 APAC Cyclic Peptide Compounds Sales by Region (2019-2024)
6.1.2 APAC Cyclic Peptide Compounds Revenue by Region (2019-2024)
6.2 APAC Cyclic Peptide Compounds Sales by Type (2019-2024)
6.3 APAC Cyclic Peptide Compounds Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cyclic Peptide Compounds by Country
7.1.1 Europe Cyclic Peptide Compounds Sales by Country (2019-2024)
7.1.2 Europe Cyclic Peptide Compounds Revenue by Country (2019-2024)
7.2 Europe Cyclic Peptide Compounds Sales by Type (2019-2024)
7.3 Europe Cyclic Peptide Compounds Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cyclic Peptide Compounds by Country
8.1.1 Middle East & Africa Cyclic Peptide Compounds Sales by Country (2019-2024)
8.1.2 Middle East & Africa Cyclic Peptide Compounds Revenue by Country (2019-2024)
8.2 Middle East & Africa Cyclic Peptide Compounds Sales by Type (2019-2024)
8.3 Middle East & Africa Cyclic Peptide Compounds Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyclic Peptide Compounds
10.3 Manufacturing Process Analysis of Cyclic Peptide Compounds
10.4 Industry Chain Structure of Cyclic Peptide Compounds
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyclic Peptide Compounds Distributors
11.3 Cyclic Peptide Compounds Customer
12 WORLD FORECAST REVIEW FOR CYCLIC PEPTIDE COMPOUNDS BY GEOGRAPHIC REGION
12.1 Global Cyclic Peptide Compounds Market Size Forecast by Region
12.1.1 Global Cyclic Peptide Compounds Forecast by Region (2025-2030)
12.1.2 Global Cyclic Peptide Compounds Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Cyclic Peptide Compounds Forecast by Type (2025-2030)
12.7 Global Cyclic Peptide Compounds Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Bicycle Therapeutics
13.1.1 Bicycle Therapeutics Company Information
13.1.2 Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolios and Specifications
13.1.3 Bicycle Therapeutics Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bicycle Therapeutics Main Business Overview
13.1.5 Bicycle Therapeutics Latest Developments
13.2 Apellis Pharmaceuticals
13.2.1 Apellis Pharmaceuticals Company Information
13.2.2 Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolios and Specifications
13.2.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Apellis Pharmaceuticals Main Business Overview
13.2.5 Apellis Pharmaceuticals Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Cyclic Peptide Compounds Product Portfolios and Specifications
13.3.3 Merck Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Bachem
13.4.1 Bachem Company Information
13.4.2 Bachem Cyclic Peptide Compounds Product Portfolios and Specifications
13.4.3 Bachem Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bachem Main Business Overview
13.4.5 Bachem Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Cyclic Peptide Compounds Product Portfolios and Specifications
13.5.3 Novartis Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Roche (Chugai Pharmabody Research)
13.6.1 Roche (Chugai Pharmabody Research) Company Information
13.6.2 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolios and Specifications
13.6.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Roche (Chugai Pharmabody Research) Main Business Overview
13.6.5 Roche (Chugai Pharmabody Research) Latest Developments
13.7 Biopharma PEG Scientific
13.7.1 Biopharma PEG Scientific Company Information
13.7.2 Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolios and Specifications
13.7.3 Biopharma PEG Scientific Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Biopharma PEG Scientific Main Business Overview
13.7.5 Biopharma PEG Scientific Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Cyclic Peptide Compounds Product Portfolios and Specifications
13.8.3 Pfizer Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 AstraZeneca
13.9.1 AstraZeneca Company Information
13.9.2 AstraZeneca Cyclic Peptide Compounds Product Portfolios and Specifications
13.9.3 AstraZeneca Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 AstraZeneca Main Business Overview
13.9.5 AstraZeneca Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Cyclic Peptide Compounds Product Portfolios and Specifications
13.10.3 Eli Lilly Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 GenScript Biotech
13.11.1 GenScript Biotech Company Information
13.11.2 GenScript Biotech Cyclic Peptide Compounds Product Portfolios and Specifications
13.11.3 GenScript Biotech Cyclic Peptide Compounds Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 GenScript Biotech Main Business Overview
13.11.5 GenScript Biotech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cyclic Peptide Compounds Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Cyclic Peptide Compounds Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Natural Cyclic Peptide
Table 4. Major Players of Synthetic Cyclic Peptide
Table 5. Global Cyclic Peptide Compounds Sales by Type (2019-2024) & (Tons)
Table 6. Global Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
Table 7. Global Cyclic Peptide Compounds Revenue by Type (2019-2024) & ($ million)
Table 8. Global Cyclic Peptide Compounds Revenue Market Share by Type (2019-2024)
Table 9. Global Cyclic Peptide Compounds Sale Price by Type (2019-2024) & (US$/kg)
Table 10. Global Cyclic Peptide Compounds Sale by Application (2019-2024) & (Tons)
Table 11. Global Cyclic Peptide Compounds Sale Market Share by Application (2019-2024)
Table 12. Global Cyclic Peptide Compounds Revenue by Application (2019-2024) & ($ million)
Table 13. Global Cyclic Peptide Compounds Revenue Market Share by Application (2019-2024)
Table 14. Global Cyclic Peptide Compounds Sale Price by Application (2019-2024) & (US$/kg)
Table 15. Global Cyclic Peptide Compounds Sales by Company (2019-2024) & (Tons)
Table 16. Global Cyclic Peptide Compounds Sales Market Share by Company (2019-2024)
Table 17. Global Cyclic Peptide Compounds Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Cyclic Peptide Compounds Revenue Market Share by Company (2019-2024)
Table 19. Global Cyclic Peptide Compounds Sale Price by Company (2019-2024) & (US$/kg)
Table 20. Key Manufacturers Cyclic Peptide Compounds Producing Area Distribution and Sales Area
Table 21. Players Cyclic Peptide Compounds Products Offered
Table 22. Cyclic Peptide Compounds Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Cyclic Peptide Compounds Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Cyclic Peptide Compounds Sales Market Share Geographic Region (2019-2024)
Table 27. Global Cyclic Peptide Compounds Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Cyclic Peptide Compounds Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Cyclic Peptide Compounds Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Cyclic Peptide Compounds Sales Market Share by Country/Region (2019-2024)
Table 31. Global Cyclic Peptide Compounds Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Cyclic Peptide Compounds Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Cyclic Peptide Compounds Sales by Country (2019-2024) & (Tons)
Table 34. Americas Cyclic Peptide Compounds Sales Market Share by Country (2019-2024)
Table 35. Americas Cyclic Peptide Compounds Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Cyclic Peptide Compounds Sales by Type (2019-2024) & (Tons)
Table 37. Americas Cyclic Peptide Compounds Sales by Application (2019-2024) & (Tons)
Table 38. APAC Cyclic Peptide Compounds Sales by Region (2019-2024) & (Tons)
Table 39. APAC Cyclic Peptide Compounds Sales Market Share by Region (2019-2024)
Table 40. APAC Cyclic Peptide Compounds Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Cyclic Peptide Compounds Sales by Type (2019-2024) & (Tons)
Table 42. APAC Cyclic Peptide Compounds Sales by Application (2019-2024) & (Tons)
Table 43. Europe Cyclic Peptide Compounds Sales by Country (2019-2024) & (Tons)
Table 44. Europe Cyclic Peptide Compounds Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Cyclic Peptide Compounds Sales by Type (2019-2024) & (Tons)
Table 46. Europe Cyclic Peptide Compounds Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Cyclic Peptide Compounds Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Cyclic Peptide Compounds Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Cyclic Peptide Compounds Sales by Type (2019-2024) & (Tons)
Table 50. Middle East & Africa Cyclic Peptide Compounds Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Cyclic Peptide Compounds
Table 52. Key Market Challenges & Risks of Cyclic Peptide Compounds
Table 53. Key Industry Trends of Cyclic Peptide Compounds
Table 54. Cyclic Peptide Compounds Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Cyclic Peptide Compounds Distributors List
Table 57. Cyclic Peptide Compounds Customer List
Table 58. Global Cyclic Peptide Compounds Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global Cyclic Peptide Compounds Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Cyclic Peptide Compounds Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas Cyclic Peptide Compounds Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Cyclic Peptide Compounds Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC Cyclic Peptide Compounds Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Cyclic Peptide Compounds Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe Cyclic Peptide Compounds Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Cyclic Peptide Compounds Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Cyclic Peptide Compounds Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Cyclic Peptide Compounds Sales Forecast by Type (2025-2030) & (Tons)
Table 69. Global Cyclic Peptide Compounds Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Cyclic Peptide Compounds Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global Cyclic Peptide Compounds Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Bicycle Therapeutics Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 73. Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolios and Specifications
Table 74. Bicycle Therapeutics Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 75. Bicycle Therapeutics Main Business
Table 76. Bicycle Therapeutics Latest Developments
Table 77. Apellis Pharmaceuticals Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 78. Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolios and Specifications
Table 79. Apellis Pharmaceuticals Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 80. Apellis Pharmaceuticals Main Business
Table 81. Apellis Pharmaceuticals Latest Developments
Table 82. Merck Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Cyclic Peptide Compounds Product Portfolios and Specifications
Table 84. Merck Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Bachem Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 88. Bachem Cyclic Peptide Compounds Product Portfolios and Specifications
Table 89. Bachem Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 90. Bachem Main Business
Table 91. Bachem Latest Developments
Table 92. Novartis Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis Cyclic Peptide Compounds Product Portfolios and Specifications
Table 94. Novartis Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 95. Novartis Main Business
Table 96. Novartis Latest Developments
Table 97. Roche (Chugai Pharmabody Research) Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 98. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolios and Specifications
Table 99. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 100. Roche (Chugai Pharmabody Research) Main Business
Table 101. Roche (Chugai Pharmabody Research) Latest Developments
Table 102. Biopharma PEG Scientific Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 103. Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolios and Specifications
Table 104. Biopharma PEG Scientific Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 105. Biopharma PEG Scientific Main Business
Table 106. Biopharma PEG Scientific Latest Developments
Table 107. Pfizer Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Cyclic Peptide Compounds Product Portfolios and Specifications
Table 109. Pfizer Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. AstraZeneca Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 113. AstraZeneca Cyclic Peptide Compounds Product Portfolios and Specifications
Table 114. AstraZeneca Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 115. AstraZeneca Main Business
Table 116. AstraZeneca Latest Developments
Table 117. Eli Lilly Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 118. Eli Lilly Cyclic Peptide Compounds Product Portfolios and Specifications
Table 119. Eli Lilly Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 120. Eli Lilly Main Business
Table 121. Eli Lilly Latest Developments
Table 122. GenScript Biotech Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 123. GenScript Biotech Cyclic Peptide Compounds Product Portfolios and Specifications
Table 124. GenScript Biotech Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 125. GenScript Biotech Main Business
Table 126. GenScript Biotech Latest Developments
Table 1. Cyclic Peptide Compounds Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Cyclic Peptide Compounds Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Natural Cyclic Peptide
Table 4. Major Players of Synthetic Cyclic Peptide
Table 5. Global Cyclic Peptide Compounds Sales by Type (2019-2024) & (Tons)
Table 6. Global Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
Table 7. Global Cyclic Peptide Compounds Revenue by Type (2019-2024) & ($ million)
Table 8. Global Cyclic Peptide Compounds Revenue Market Share by Type (2019-2024)
Table 9. Global Cyclic Peptide Compounds Sale Price by Type (2019-2024) & (US$/kg)
Table 10. Global Cyclic Peptide Compounds Sale by Application (2019-2024) & (Tons)
Table 11. Global Cyclic Peptide Compounds Sale Market Share by Application (2019-2024)
Table 12. Global Cyclic Peptide Compounds Revenue by Application (2019-2024) & ($ million)
Table 13. Global Cyclic Peptide Compounds Revenue Market Share by Application (2019-2024)
Table 14. Global Cyclic Peptide Compounds Sale Price by Application (2019-2024) & (US$/kg)
Table 15. Global Cyclic Peptide Compounds Sales by Company (2019-2024) & (Tons)
Table 16. Global Cyclic Peptide Compounds Sales Market Share by Company (2019-2024)
Table 17. Global Cyclic Peptide Compounds Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Cyclic Peptide Compounds Revenue Market Share by Company (2019-2024)
Table 19. Global Cyclic Peptide Compounds Sale Price by Company (2019-2024) & (US$/kg)
Table 20. Key Manufacturers Cyclic Peptide Compounds Producing Area Distribution and Sales Area
Table 21. Players Cyclic Peptide Compounds Products Offered
Table 22. Cyclic Peptide Compounds Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Cyclic Peptide Compounds Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Cyclic Peptide Compounds Sales Market Share Geographic Region (2019-2024)
Table 27. Global Cyclic Peptide Compounds Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Cyclic Peptide Compounds Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Cyclic Peptide Compounds Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Cyclic Peptide Compounds Sales Market Share by Country/Region (2019-2024)
Table 31. Global Cyclic Peptide Compounds Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Cyclic Peptide Compounds Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Cyclic Peptide Compounds Sales by Country (2019-2024) & (Tons)
Table 34. Americas Cyclic Peptide Compounds Sales Market Share by Country (2019-2024)
Table 35. Americas Cyclic Peptide Compounds Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Cyclic Peptide Compounds Sales by Type (2019-2024) & (Tons)
Table 37. Americas Cyclic Peptide Compounds Sales by Application (2019-2024) & (Tons)
Table 38. APAC Cyclic Peptide Compounds Sales by Region (2019-2024) & (Tons)
Table 39. APAC Cyclic Peptide Compounds Sales Market Share by Region (2019-2024)
Table 40. APAC Cyclic Peptide Compounds Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Cyclic Peptide Compounds Sales by Type (2019-2024) & (Tons)
Table 42. APAC Cyclic Peptide Compounds Sales by Application (2019-2024) & (Tons)
Table 43. Europe Cyclic Peptide Compounds Sales by Country (2019-2024) & (Tons)
Table 44. Europe Cyclic Peptide Compounds Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Cyclic Peptide Compounds Sales by Type (2019-2024) & (Tons)
Table 46. Europe Cyclic Peptide Compounds Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Cyclic Peptide Compounds Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Cyclic Peptide Compounds Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Cyclic Peptide Compounds Sales by Type (2019-2024) & (Tons)
Table 50. Middle East & Africa Cyclic Peptide Compounds Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Cyclic Peptide Compounds
Table 52. Key Market Challenges & Risks of Cyclic Peptide Compounds
Table 53. Key Industry Trends of Cyclic Peptide Compounds
Table 54. Cyclic Peptide Compounds Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Cyclic Peptide Compounds Distributors List
Table 57. Cyclic Peptide Compounds Customer List
Table 58. Global Cyclic Peptide Compounds Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global Cyclic Peptide Compounds Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Cyclic Peptide Compounds Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas Cyclic Peptide Compounds Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Cyclic Peptide Compounds Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC Cyclic Peptide Compounds Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Cyclic Peptide Compounds Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe Cyclic Peptide Compounds Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Cyclic Peptide Compounds Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Cyclic Peptide Compounds Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Cyclic Peptide Compounds Sales Forecast by Type (2025-2030) & (Tons)
Table 69. Global Cyclic Peptide Compounds Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Cyclic Peptide Compounds Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global Cyclic Peptide Compounds Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Bicycle Therapeutics Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 73. Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolios and Specifications
Table 74. Bicycle Therapeutics Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 75. Bicycle Therapeutics Main Business
Table 76. Bicycle Therapeutics Latest Developments
Table 77. Apellis Pharmaceuticals Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 78. Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolios and Specifications
Table 79. Apellis Pharmaceuticals Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 80. Apellis Pharmaceuticals Main Business
Table 81. Apellis Pharmaceuticals Latest Developments
Table 82. Merck Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Cyclic Peptide Compounds Product Portfolios and Specifications
Table 84. Merck Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Bachem Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 88. Bachem Cyclic Peptide Compounds Product Portfolios and Specifications
Table 89. Bachem Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 90. Bachem Main Business
Table 91. Bachem Latest Developments
Table 92. Novartis Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 93. Novartis Cyclic Peptide Compounds Product Portfolios and Specifications
Table 94. Novartis Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 95. Novartis Main Business
Table 96. Novartis Latest Developments
Table 97. Roche (Chugai Pharmabody Research) Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 98. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolios and Specifications
Table 99. Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 100. Roche (Chugai Pharmabody Research) Main Business
Table 101. Roche (Chugai Pharmabody Research) Latest Developments
Table 102. Biopharma PEG Scientific Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 103. Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolios and Specifications
Table 104. Biopharma PEG Scientific Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 105. Biopharma PEG Scientific Main Business
Table 106. Biopharma PEG Scientific Latest Developments
Table 107. Pfizer Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Cyclic Peptide Compounds Product Portfolios and Specifications
Table 109. Pfizer Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. AstraZeneca Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 113. AstraZeneca Cyclic Peptide Compounds Product Portfolios and Specifications
Table 114. AstraZeneca Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 115. AstraZeneca Main Business
Table 116. AstraZeneca Latest Developments
Table 117. Eli Lilly Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 118. Eli Lilly Cyclic Peptide Compounds Product Portfolios and Specifications
Table 119. Eli Lilly Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 120. Eli Lilly Main Business
Table 121. Eli Lilly Latest Developments
Table 122. GenScript Biotech Basic Information, Cyclic Peptide Compounds Manufacturing Base, Sales Area and Its Competitors
Table 123. GenScript Biotech Cyclic Peptide Compounds Product Portfolios and Specifications
Table 124. GenScript Biotech Cyclic Peptide Compounds Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2019-2024)
Table 125. GenScript Biotech Main Business
Table 126. GenScript Biotech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Cyclic Peptide Compounds
Figure 2. Cyclic Peptide Compounds Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyclic Peptide Compounds Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Cyclic Peptide Compounds Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Cyclic Peptide Compounds Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Cyclic Peptide Compounds Sales Market Share by Country/Region (2023)
Figure 10. Cyclic Peptide Compounds Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Natural Cyclic Peptide
Figure 12. Product Picture of Synthetic Cyclic Peptide
Figure 13. Global Cyclic Peptide Compounds Sales Market Share by Type in 2023
Figure 14. Global Cyclic Peptide Compounds Revenue Market Share by Type (2019-2024)
Figure 15. Cyclic Peptide Compounds Consumed in Biopharmaceutical
Figure 16. Global Cyclic Peptide Compounds Market: Biopharmaceutical (2019-2024) & (Tons)
Figure 17. Cyclic Peptide Compounds Consumed in Environmental Protection
Figure 18. Global Cyclic Peptide Compounds Market: Environmental Protection (2019-2024) & (Tons)
Figure 19. Cyclic Peptide Compounds Consumed in Scientific Research
Figure 20. Global Cyclic Peptide Compounds Market: Scientific Research (2019-2024) & (Tons)
Figure 21. Cyclic Peptide Compounds Consumed in Others
Figure 22. Global Cyclic Peptide Compounds Market: Others (2019-2024) & (Tons)
Figure 23. Global Cyclic Peptide Compounds Sale Market Share by Application (2023)
Figure 24. Global Cyclic Peptide Compounds Revenue Market Share by Application in 2023
Figure 25. Cyclic Peptide Compounds Sales by Company in 2023 (Tons)
Figure 26. Global Cyclic Peptide Compounds Sales Market Share by Company in 2023
Figure 27. Cyclic Peptide Compounds Revenue by Company in 2023 ($ millions)
Figure 28. Global Cyclic Peptide Compounds Revenue Market Share by Company in 2023
Figure 29. Global Cyclic Peptide Compounds Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Cyclic Peptide Compounds Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Cyclic Peptide Compounds Sales 2019-2024 (Tons)
Figure 32. Americas Cyclic Peptide Compounds Revenue 2019-2024 ($ millions)
Figure 33. APAC Cyclic Peptide Compounds Sales 2019-2024 (Tons)
Figure 34. APAC Cyclic Peptide Compounds Revenue 2019-2024 ($ millions)
Figure 35. Europe Cyclic Peptide Compounds Sales 2019-2024 (Tons)
Figure 36. Europe Cyclic Peptide Compounds Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Cyclic Peptide Compounds Sales 2019-2024 (Tons)
Figure 38. Middle East & Africa Cyclic Peptide Compounds Revenue 2019-2024 ($ millions)
Figure 39. Americas Cyclic Peptide Compounds Sales Market Share by Country in 2023
Figure 40. Americas Cyclic Peptide Compounds Revenue Market Share by Country (2019-2024)
Figure 41. Americas Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
Figure 42. Americas Cyclic Peptide Compounds Sales Market Share by Application (2019-2024)
Figure 43. United States Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Cyclic Peptide Compounds Sales Market Share by Region in 2023
Figure 48. APAC Cyclic Peptide Compounds Revenue Market Share by Region (2019-2024)
Figure 49. APAC Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
Figure 50. APAC Cyclic Peptide Compounds Sales Market Share by Application (2019-2024)
Figure 51. China Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 55. India Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Cyclic Peptide Compounds Sales Market Share by Country in 2023
Figure 59. Europe Cyclic Peptide Compounds Revenue Market Share by Country (2019-2024)
Figure 60. Europe Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
Figure 61. Europe Cyclic Peptide Compounds Sales Market Share by Application (2019-2024)
Figure 62. Germany Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 63. France Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Cyclic Peptide Compounds Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Cyclic Peptide Compounds Sales Market Share by Application (2019-2024)
Figure 70. Egypt Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Cyclic Peptide Compounds in 2023
Figure 76. Manufacturing Process Analysis of Cyclic Peptide Compounds
Figure 77. Industry Chain Structure of Cyclic Peptide Compounds
Figure 78. Channels of Distribution
Figure 79. Global Cyclic Peptide Compounds Sales Market Forecast by Region (2025-2030)
Figure 80. Global Cyclic Peptide Compounds Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Cyclic Peptide Compounds Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Cyclic Peptide Compounds Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Cyclic Peptide Compounds Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Cyclic Peptide Compounds Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Cyclic Peptide Compounds
Figure 2. Cyclic Peptide Compounds Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyclic Peptide Compounds Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Cyclic Peptide Compounds Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Cyclic Peptide Compounds Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Cyclic Peptide Compounds Sales Market Share by Country/Region (2023)
Figure 10. Cyclic Peptide Compounds Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Natural Cyclic Peptide
Figure 12. Product Picture of Synthetic Cyclic Peptide
Figure 13. Global Cyclic Peptide Compounds Sales Market Share by Type in 2023
Figure 14. Global Cyclic Peptide Compounds Revenue Market Share by Type (2019-2024)
Figure 15. Cyclic Peptide Compounds Consumed in Biopharmaceutical
Figure 16. Global Cyclic Peptide Compounds Market: Biopharmaceutical (2019-2024) & (Tons)
Figure 17. Cyclic Peptide Compounds Consumed in Environmental Protection
Figure 18. Global Cyclic Peptide Compounds Market: Environmental Protection (2019-2024) & (Tons)
Figure 19. Cyclic Peptide Compounds Consumed in Scientific Research
Figure 20. Global Cyclic Peptide Compounds Market: Scientific Research (2019-2024) & (Tons)
Figure 21. Cyclic Peptide Compounds Consumed in Others
Figure 22. Global Cyclic Peptide Compounds Market: Others (2019-2024) & (Tons)
Figure 23. Global Cyclic Peptide Compounds Sale Market Share by Application (2023)
Figure 24. Global Cyclic Peptide Compounds Revenue Market Share by Application in 2023
Figure 25. Cyclic Peptide Compounds Sales by Company in 2023 (Tons)
Figure 26. Global Cyclic Peptide Compounds Sales Market Share by Company in 2023
Figure 27. Cyclic Peptide Compounds Revenue by Company in 2023 ($ millions)
Figure 28. Global Cyclic Peptide Compounds Revenue Market Share by Company in 2023
Figure 29. Global Cyclic Peptide Compounds Sales Market Share by Geographic Region (2019-2024)
Figure 30. Global Cyclic Peptide Compounds Revenue Market Share by Geographic Region in 2023
Figure 31. Americas Cyclic Peptide Compounds Sales 2019-2024 (Tons)
Figure 32. Americas Cyclic Peptide Compounds Revenue 2019-2024 ($ millions)
Figure 33. APAC Cyclic Peptide Compounds Sales 2019-2024 (Tons)
Figure 34. APAC Cyclic Peptide Compounds Revenue 2019-2024 ($ millions)
Figure 35. Europe Cyclic Peptide Compounds Sales 2019-2024 (Tons)
Figure 36. Europe Cyclic Peptide Compounds Revenue 2019-2024 ($ millions)
Figure 37. Middle East & Africa Cyclic Peptide Compounds Sales 2019-2024 (Tons)
Figure 38. Middle East & Africa Cyclic Peptide Compounds Revenue 2019-2024 ($ millions)
Figure 39. Americas Cyclic Peptide Compounds Sales Market Share by Country in 2023
Figure 40. Americas Cyclic Peptide Compounds Revenue Market Share by Country (2019-2024)
Figure 41. Americas Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
Figure 42. Americas Cyclic Peptide Compounds Sales Market Share by Application (2019-2024)
Figure 43. United States Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 44. Canada Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 45. Mexico Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 46. Brazil Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 47. APAC Cyclic Peptide Compounds Sales Market Share by Region in 2023
Figure 48. APAC Cyclic Peptide Compounds Revenue Market Share by Region (2019-2024)
Figure 49. APAC Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
Figure 50. APAC Cyclic Peptide Compounds Sales Market Share by Application (2019-2024)
Figure 51. China Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 52. Japan Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 53. South Korea Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 54. Southeast Asia Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 55. India Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 56. Australia Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 57. China Taiwan Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 58. Europe Cyclic Peptide Compounds Sales Market Share by Country in 2023
Figure 59. Europe Cyclic Peptide Compounds Revenue Market Share by Country (2019-2024)
Figure 60. Europe Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
Figure 61. Europe Cyclic Peptide Compounds Sales Market Share by Application (2019-2024)
Figure 62. Germany Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 63. France Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 64. UK Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 65. Italy Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 66. Russia Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 67. Middle East & Africa Cyclic Peptide Compounds Sales Market Share by Country (2019-2024)
Figure 68. Middle East & Africa Cyclic Peptide Compounds Sales Market Share by Type (2019-2024)
Figure 69. Middle East & Africa Cyclic Peptide Compounds Sales Market Share by Application (2019-2024)
Figure 70. Egypt Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 71. South Africa Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 72. Israel Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 73. Turkey Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 74. GCC Countries Cyclic Peptide Compounds Revenue Growth 2019-2024 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Cyclic Peptide Compounds in 2023
Figure 76. Manufacturing Process Analysis of Cyclic Peptide Compounds
Figure 77. Industry Chain Structure of Cyclic Peptide Compounds
Figure 78. Channels of Distribution
Figure 79. Global Cyclic Peptide Compounds Sales Market Forecast by Region (2025-2030)
Figure 80. Global Cyclic Peptide Compounds Revenue Market Share Forecast by Region (2025-2030)
Figure 81. Global Cyclic Peptide Compounds Sales Market Share Forecast by Type (2025-2030)
Figure 82. Global Cyclic Peptide Compounds Revenue Market Share Forecast by Type (2025-2030)
Figure 83. Global Cyclic Peptide Compounds Sales Market Share Forecast by Application (2025-2030)
Figure 84. Global Cyclic Peptide Compounds Revenue Market Share Forecast by Application (2025-2030)
